MELISSA BECKER: Open Payments
NPI 1326706730 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$155 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $42 · 2025 $155
Food & beverage: $155
| Company | Payments | Amount |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | 2 | $68 |
| Calliditas Therapeutics US Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: ENVARSUS, TARPEYO, PREVYMIS, LIVTENCITY, XIFAXAN.
Industry payments across OH — which companies pay providers there.
